Impact of human immunodeficiency virus infection on arterial stiffness and wave reflections in the early disease stages

Artery Research

Volumn 3, Issue 3, 2009, Pages 104-110

  Vlachopoulos, Charalambos ^a   Sambatakou, Helen ^b   Tsiachris, Dimitris ^a   Mariolis, Ilias ^b   Aznaouridis, Konstantinos ^a   Ioakeimidis, Nikolaos ^a   Archimandritis, Athanasios J ^b   Stefanadis, Christodoulos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Acquired immunodeficiency syndrome; Aortic stiffness; Cytokines; Vascular biology; Wave reflections

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ANTHROPOMETRY; ARTERIAL STIFFNESS; ARTICLE; BIOCHEMISTRY; CIGARETTE SMOKING; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PULSE WAVE; SEX DIFFERENCE;

EID: 70449122135     PISSN: 18729312     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.artres.2009.08.001     Document Type: Article

References (34)

1. Friis-Møller N., Sabin C.A., Weber R., d'Arminio Monforte A., El-Sadr W.M., Reiss P., et al. Combination antiretroviral therapy and the risk of myocardial infarction [published correction appears in N Engl J Med 2004;350:955]. Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group 349 (2003) 1993-2003
2. Currier J.S., Taylor A., Boyd F., Dezii C.M., Kawabata H., Burtcel F., et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 33 (2003) 506-512
3. Bozzette S.A., Ake C.F., Tam H.K., Chang S.W., and Louis T.A. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348 (2003) 702-710
4. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., et al., On behalf of the European Network for Non-invasive Investigation of Large Arteries. Abridged version of the expert consensus document on arterial stiffness. Artery Res 1 (2007) 2-12
5. Schillaci G., De Socio G.V., Pirro M., Savarese G., Mannarino M.R., Baldelli F., et al. Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. Arterioscler Thromb Vasc Biol 25 (2005) 2381-2385
6. Schillacci G., De Socio G.V., Pucci G., Mannarino M.R., Helou J., Pirro M., et al. Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension 52 2 (2008) 308-313
7. van Wijk J.P., de Koning E.J., Cabezas M.C., Joven J., op't Roodt J., Rabelink T.J., et al. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol 47 6 (2006) 1117-1123
8. Boccara F., Simon T., Lacombe K., Cohen A., Laloux B., Bozec E., et al. Influence of pravastatin on carotid artery structure and function in dyslipidemic HIV-infected patients receiving antiretroviral therapy. AIDS 20 18 (2006) 2395-2398
9. Sevastianova K., Sutinen J., Westerbacka J., Ristola M., and Yki-Jarvinen H. Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy. Antivir Ther 10 (2005) 925-935
10. Vlachopoulos C., Dima I., Aznaouridis K., Vasiliadou C., Ioakeimidis N., Aggeli C., et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112 (2005) 2193-2200
11. Vlachopoulos C., Pietri P., Aznaouridis K., Vyssoulis G., Vasiliadou C., Bratsas A., et al. Relationship of fibrinogen with arterial stiffness and wave reflections. J Hypertens 10 (2007) 2110-2116
12. Mattace-Raso F.U., van der Cammen T.J., van der Meer I.M., Schalekamp M.A., Asmar R., Hofman A., et al. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 176 1 (2004) 111-116
13. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41 RR-17 (1992) 1-19
14. Vlachopoulos C., and O'Rourke M. Genesis of the normal and abnormal arterial pulse. Curr Probl Cardiol 25 (2000) 297-368
15. Raggi P., Bellasi A., Ferramosca E., Islam T., Muntner P., and Block G.A. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 71 8 (2007) 802-807
16. Asmar R., Benetos A., Topouchian J., Laurent P., Pannier B., Brisac A.M., et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 26 (1995) 485-490
17. Agabiti-Rosei E., Mancia G., O'Rourke M.F., Roman M.J., Safar M.E., Smulyan H., et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 50 1 (2007) 154-160
18. Carr A., Grund B., Neuhaus J., El-Sadr W.M., Grandits G., Gibert C., et al. The SMART Study Investigators. Asymptomatic myocardial ischaemia in HIV-infected adults. AIDS 22 (2008) 257-267
19. Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4 count-guided interruption of antiretroviral treatment. N Engl J Med 355 (2006) 2283-2296
20. Bonnet D., Aggoun Y., Szezepanski I., Bellal N., and Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 18 (2004) 1037-1041
21. Stein J.H., Klein M.A., Bellehumeur J.L., McBride P.E., Wiebe D.A., Otvos J.D., et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 104 (2001) 257-262
22. Riddler S.A., Smit E., Cole S.R., Chmiel J.S., Dobs A., Palella F., et al. Impact of HIV infection and HAART on serum lipids in men. JAMA 289 (2003) 2978-2982
23. Booth A.D., Wallace S., McEniery C.M., Yasmin, Brown J., Jayne D.R., and Wilkinson I.B. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 50 2 (2004) 581-588
24. Mäki-Petäjä K.M., Hall F.C., Booth A.D., Wallace S.M., Yasmin, Bearcroft P.W., et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 114 11 (2006) 1185-1192
25. de Gaetano Donati K., Rabagliati R., Iacoviello L., and Cauda R. HIV infection, HAART and endothelial adhesion molecules. Lancet Infect Dis 4 (2004) 213-222
26. Sudano I., Spieker L.E., Noll G., Corti R., Weber R., and Lüscher T.F. Cardiovascular disease in HIV infection. Am Heart J 151 (2006) 1147-1155
27. Ren Z., Yao Q., and Chen C. HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab Invest 82 3 (2002) 245-255
28. Saumoy M., López-Dupla M., Veloso S., Alonso-Villaverde C., Domingo P., Broch M., et al. The IL-6 system in HIV-1-infection and in HAART-related fat redistribution syndromes. AIDS 22 7 (2008) 893-896
29. Clapp B.R., Hirschfield G.M., Storry C., Gallimore J.R., Stidwill R.P., Singer M., et al. Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 111 (2005) 1530-1536
30. Lau B., Sharrett A.R., Kingsley L.A., Post W., Palella F.J., Visscher B., et al. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med 166 (2006) 64-70
31. Schiffrin E.L. Vascular stiffening and arterial compliance. Implications for systolic blood pressure. Am J Hypertens 17 (2004) 39S-48S
32. Eugenin E.A., Morgello S., Klotman M.E., Mosoian A., Lento P.A., Berman J.W., et al. Human Immunodeficiency Virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro. Am J Pathol 172 (2008) 1100-1111
33. Pirro M., Schillaci G., Savarese G., Gemelli F., Vaudo G., Siepi D., et al. Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolemia. Eur J Clin Invest 34 (2004) 335-341
34. Grunfeld C., Kotler D.P., Arnett D.K., Falutz J.M., Haffner S.M., Hruz P., et al., for Working Group 1. Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. Circulation 118 2 (2008) e20-e28